CORCEPT THERAPEUTICS INC Annual Operating Margin in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Corcept Therapeutics Inc quarterly/annual Operating Margin history and growth rate from 2016 to 2023.
  • Corcept Therapeutics Inc Operating Margin for the quarter ending September 30, 2024 was 22.8 %, a 4.63% increase year-over-year.
  • Corcept Therapeutics Inc annual Operating Margin for 2023 was 22.2 %, a 20.7% decline from 2022.
  • Corcept Therapeutics Inc annual Operating Margin for 2022 was 28 %, a 17.6% decline from 2021.
  • Corcept Therapeutics Inc annual Operating Margin for 2021 was 34 %, a 6.13% decline from 2020.
Operating Margin, Annual (%)
Operating Margin, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 22.2 -5.79 -20.7% Jan 1, 2023 Dec 31, 2023
2022 28 -5.98 -17.6% Jan 1, 2022 Dec 31, 2022
2021 34 -2.22 -6.13% Jan 1, 2021 Dec 31, 2021
2020 36.2 -0.19 -0.52% Jan 1, 2020 Dec 31, 2020
2019 36.4 +0.79 +2.22% Jan 1, 2019 Dec 31, 2019
2018 35.6 +2.42 +7.29% Jan 1, 2018 Dec 31, 2018
2017 33.2 +20.7 +165% Jan 1, 2017 Dec 31, 2017
2016 12.5 Jan 1, 2016 Dec 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.